Justice, Reconciliation, and State-Building in Post-Gaddafi Libya
Contemporary Arab Affairs · 21.06.2022 · 15 (2) · 3-24
DOI: 10.1525/caa.2022.15.2.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Arab Affairs, erschienen am 21.06.2022. Verfasst von Youssef Mohammad Sawani. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
This article argues that the transitional justice (TJ) approach in post-Gaddafi Libya has failed because it lacked national reconciliation. Libya’s transition experience did not include reconciliation and agreement on a new social contract, and this not only perpetuated conflict, exclusion, and division, but also frustrated the pursuit of a peace, and made democratic transition a remote possibility. Taking stock from local and relevant comparative international experiences, the main argument is that the nexus between TJ and peacebuilding should be replaced, or at least coupled, with an inclusive national reconciliation process that yields an agreement on a new social contract. This implies the urgent need to go beyond the often externally promoted TJ and narrow state-centric processes in a country where the state itself has been destroyed and its future form remains highly contested with some actors such as Islamists with illiberal notions contesting the nation-state and its legitimacy, authority, and the issue of human rights.
Zitieren
APA
Sawani, Y. M. (2022). Justice, Reconciliation, and State-Building in Post-Gaddafi Libya. Contemporary Arab Affairs, 15(2), 3-24. https://doi.org/10.1525/caa.2022.15.2.3
Vancouver
Sawani YM. Justice, Reconciliation, and State-Building in Post-Gaddafi Libya. Contemporary Arab Affairs. 2022;15(2):3-24. doi:10.1525/caa.2022.15.2.3
BibTeX
@article{Sawani2022,
author = {Sawani, Youssef Mohammad},
title = {Justice, Reconciliation, and State-Building in Post-Gaddafi Libya},
journal = {Contemporary Arab Affairs},
year = {2022},
volume = {15},
number = {2},
pages = {3--24},
doi = {10.1525/caa.2022.15.2.3}
}
EUVIMED